Medicover AB represents a strong commitment to healthcare and quality services. With a focus on patient-centered care, the company promotes accessibility, innovation, and personalized medical solutions. Medicover AB strives to deliver comprehensive healthcare solutions by blending modern technology with a compassionate approach. Their corporate philosophy revolves around continuously improving patient outcomes and enhancing the overall healthcare experience. By combining the expertise of their dedicated professionals and advanced medical facilities, Medicover AB aims to provide exceptional healthcare services to individuals and families. This commitment to excellence and patient well-being is at the core of Medicover AB's values and corporate philosophy.

Medicover AB is primarily present in various countries and regions across Europe. With its headquarters in Sweden, Medicover AB has a strong presence in Poland, Romania, Ukraine, Germany, Hungary, and Serbia. Through its extensive network of medical clinics, hospitals, and laboratories, Medicover AB provides a wide range of healthcare services, including primary care, specialist care, diagnostics, and laboratory work. The company's commitment to delivering high-quality healthcare services has earned it a reputation as a trusted healthcare provider in the regions where it operates.

Medicover AB, a leading healthcare and diagnostic services provider, has achieved several significant milestones. The company's commitment to providing high-quality healthcare has led to expanding its presence in various countries, resulting in a strong global footprint. Medicover's milestones include successful acquisitions and collaborations with industry leaders to enhance its service offerings and geographic reach. Additionally, the company's focus on innovation and cutting-edge technology has led to the implementation of advanced medical solutions, improving patient outcomes. Medicover AB's remarkable achievements and continuous growth highlight its dedication to providing comprehensive and accessible healthcare solutions to individuals and communities worldwide.

Medicover AB is a renowned healthcare company specializing in medical services, diagnostics, and fertility treatments. Founded in 1995, Medicover has grown to become a leading provider of private healthcare services across Europe. With a strong presence in 15 countries, Medicover offers a wide range of services, including primary care, specialty care, hospital services, and laboratory diagnostics. The company's commitment to exceptional patient care, advanced medical technologies, and innovative solutions has earned them a trusted reputation in the healthcare industry. Medicover AB continues to expand its operations globally, providing quality healthcare solutions to individuals and families worldwide.

The main competitors of Medicover AB in the market include listed healthcare companies such as Capio AB, Ramsay Générale de Santé, and Fresenius SE & Co. KGaA. These competitors operate in various healthcare segments, including primary care, hospital care, and diagnostic services. However, Medicover AB differentiates itself through its integrated healthcare model, providing a comprehensive range of services covering primary and specialty care, diagnostic imaging, and laboratory analysis. With a strong focus on patient-centric care and technological innovation, Medicover AB remains a key player in the competitive healthcare market.

Medicover AB is primarily active in the healthcare industry.

The business model of Medicover AB revolves around providing a comprehensive range of healthcare services to individuals, families, and corporate clients. Medicover AB operates a network of medical clinics, hospitals, and laboratories, offering a wide range of healthcare services such as primary care, specialized care, diagnostics, and outpatient surgery. By integrating healthcare facilities and services, Medicover AB aims to provide high-quality medical care, convenience, and efficient healthcare solutions. This Swedish multinational healthcare company emphasizes patient-centric care and combines medical expertise with the latest technological advancements to ensure optimal health outcomes for its customers. With a strong focus on preventive care, Medicover AB aims to promote and facilitate healthier lifestyles.

The Medicover P/E ratio is 82.85.

The Medicover P/S ratio is 1.16.

The Quality Investing for Medicover is 2/10.

The expected Medicover revenue is 2.39 B EUR.

The expected Medicover profit is 33.41 M EUR.

Medicover AB is a multinational company operating in the healthcare, diagnostic, and nursing sectors. Its business model focuses on providing comprehensive healthcare to patients, from diagnostics to treatment. Medicover offers a wide range of services including general medicine, dentistry, gynecology, dermatology, ophthalmology, pediatrics, and more. The company also operates its own pharmacies and laboratories, and offers home care, elderly care, and psychiatric care. Medicover has a strong presence in Europe, with clinics and healthcare centers in various countries including Sweden, Poland, Germany, Romania, Hungary, Ukraine, and Slovakia. The company's strategy emphasizes innovation and effectiveness in meeting patients' healthcare needs, through collaboration with doctors and continuous professional development. Technology plays a crucial role in Medicover's business model, with the use of advanced medical devices, IT systems, and telemedicine to improve patient diagnosis and treatment. The company aims to provide comprehensive healthcare by integrating different healthcare services, and offers additional health products such as supplements, vitamins, and painkillers in its pharmacies. Overall, Medicover strives to improve patient healthcare through qualified staff, technology, and collaboration with industry professionals.

Medicover pays a dividend of 0.12 EUR distributed over payouts per year.

The dividend cannot currently be calculated for Medicover or the company does not pay out a dividend.

The ISIN of Medicover is SE0009778848.

The WKN of Medicover is A2DRQV.

The ticker of Medicover is MCOV B.ST.

Over the past 12 months, Medicover paid a dividend of 0.12 EUR . This corresponds to a dividend yield of about 0.65 %. For the coming 12 months, Medicover is expected to pay a dividend of 0.12 EUR.

The current dividend yield of Medicover is 0.65 %.

Medicover pays a quarterly dividend. This is distributed in the months of May, May, May, May.

Medicover paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.12 EUR are expected. This corresponds to a dividend yield of 0.65 %.

Medicover is assigned to the 'Health' sector.

To receive the latest dividend of Medicover from 5/8/2024 amounting to 0.12 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

The last dividend was paid out on 5/8/2024.

In the year 2024, Medicover distributed 0.12 EUR as dividends.

The dividends of Medicover are distributed in EUR.